Skip to Main Content

Author Details

Lionel Feigenbaum
Science Applications International Corporation/Frederick
1981
116
62
PMIDPaper TitleJournal TitlePublished Year
32143838NK cells prevent T cell lymphoma development in T cell receptor-transgenic mice.Cell Immunol2020
32143838NK cells prevent T cell lymphoma development in T cell receptor-transgenic mice.Cell Immunol2020
31825834Visualizing the Selectivity and Dynamics of Interferon Signaling In Vivo.Cell Rep2019
31825834Visualizing the Selectivity and Dynamics of Interferon Signaling In Vivo.Cell Rep2019
28007907H255Y and K508R missense mutations in tumour suppressor folliculin (FLCN) promote kidney cell proliferation.Hum Mol Genet2017
28990932Uromodulin p.Cys147Trp mutation drives kidney disease by activating ER stress and apoptosis.J Clin Invest2017
28007907H255Y and K508R missense mutations in tumour suppressor folliculin (FLCN) promote kidney cell proliferation.Hum Mol Genet2017
28990932Uromodulin p.Cys147Trp mutation drives kidney disease by activating ER stress and apoptosis.J Clin Invest2017
27468693Activated c-Kit receptor in the heart promotes cardiac repair and regeneration after injury.Cell Death Dis2016
27468693Activated c-Kit receptor in the heart promotes cardiac repair and regeneration after injury.Cell Death Dis2016
25539812TSLP expression: analysis with a ZsGreen TSLP reporter mouse.J Immunol2015
25848867Let-7 microRNAs target the lineage-specific transcription factor PLZF to regulate terminal NKT cell differentiation and effector function.Nat Immunol2015
25501630Dynamic expression of transcription factors T-bet and GATA-3 by regulatory T cells maintains immunotolerance.Nat Immunol2015
25706117Expression of the SNARE protein SNAP-23 is essential for cell survival.PLoS One2015
25539812TSLP expression: analysis with a ZsGreen TSLP reporter mouse.J Immunol2015
26018935Enhanced T-cell activation and differentiation in lymphocytes from transgenic mice expressing ubiquitination-resistant 2KR LAT molecules.Gene Ther2015
25848867Let-7 microRNAs target the lineage-specific transcription factor PLZF to regulate terminal NKT cell differentiation and effector function.Nat Immunol2015
26018935Enhanced T-cell activation and differentiation in lymphocytes from transgenic mice expressing ubiquitination-resistant 2KR LAT molecules.Gene Ther2015
25706117Expression of the SNARE protein SNAP-23 is essential for cell survival.PLoS One2015
25501630Dynamic expression of transcription factors T-bet and GATA-3 by regulatory T cells maintains immunotolerance.Nat Immunol2015
23401136Normal viability of Kai1/Cd82 deficient mice.Mol Carcinog2014
25369133"Glowing head" mice: a genetic tool enabling reliable preclinical image-based evaluation of cancers in immunocompetent allografts.PLoS One2014
25483777B cell super-enhancers and regulatory clusters recruit AID tumorigenic activity.Cell2014
23401136Normal viability of Kai1/Cd82 deficient mice.Mol Carcinog2014
25217524The Notch pathway inhibits TGFβ signaling in breast cancer through HEYL-mediated crosstalk.Cancer Res2014
24909888Activated T cells secrete an alternatively spliced form of common γ-chain that inhibits cytokine signaling and exacerbates inflammation.Immunity2014
24632714A mouse model of HIES reveals pro- and anti-inflammatory functions of STAT3.Blood2014
24842372CtIP-mediated resection is essential for viability and can operate independently of BRCA1.J Exp Med2014
24880459The transcription factor ThPOK suppresses Runx3 and imposes CD4(+) lineage fate by inducing the SOCS suppressors of cytokine signaling.Nat Immunol2014
25483777B cell super-enhancers and regulatory clusters recruit AID tumorigenic activity.Cell2014
25217524The Notch pathway inhibits TGFβ signaling in breast cancer through HEYL-mediated crosstalk.Cancer Res2014
25369133"Glowing head" mice: a genetic tool enabling reliable preclinical image-based evaluation of cancers in immunocompetent allografts.PLoS One2014
24842372CtIP-mediated resection is essential for viability and can operate independently of BRCA1.J Exp Med2014
24909888Activated T cells secrete an alternatively spliced form of common γ-chain that inhibits cytokine signaling and exacerbates inflammation.Immunity2014
24880459The transcription factor ThPOK suppresses Runx3 and imposes CD4(+) lineage fate by inducing the SOCS suppressors of cytokine signaling.Nat Immunol2014
24632714A mouse model of HIES reveals pro- and anti-inflammatory functions of STAT3.Blood2014
23310955Thpok-independent repression of Runx3 by Gata3 during CD4+ T-cell differentiation in the thymus.Eur J Immunol2013
23908463Ikaros is required to survive positive selection and to maintain clonal diversity during T-cell development in the thymus.Blood2013
23819124Mouse prostate epithelial luminal cells lineage originate in the basal layer where the primitive stem/early progenitor cells reside: implications for identifying prostate cancer stem cells.Biomed Res Int2013
23904478Insulin-dependent diabetes induced by pancreatic beta cell expression of IL-15 and IL-15Rα.Proc Natl Acad Sci U S A2013
24034254Lck availability during thymic selection determines the recognition specificity of the T cell repertoire.Cell2013
23746651Foxp3 transcription factor is proapoptotic and lethal to developing regulatory T cells unless counterbalanced by cytokine survival signals.Immunity2013
23310955Thpok-independent repression of Runx3 by Gata3 during CD4+ T-cell differentiation in the thymus.Eur J Immunol2013
23204239High-avidity T cells are preferentially tolerized in the tumor microenvironment.Cancer Res2013
23706737Global regulation of promoter melting in naive lymphocytes.Cell2013
23908463Ikaros is required to survive positive selection and to maintain clonal diversity during T-cell development in the thymus.Blood2013
23904478Insulin-dependent diabetes induced by pancreatic beta cell expression of IL-15 and IL-15Rα.Proc Natl Acad Sci U S A2013
23819124Mouse prostate epithelial luminal cells lineage originate in the basal layer where the primitive stem/early progenitor cells reside: implications for identifying prostate cancer stem cells.Biomed Res Int2013
24034254Lck availability during thymic selection determines the recognition specificity of the T cell repertoire.Cell2013
23746651Foxp3 transcription factor is proapoptotic and lethal to developing regulatory T cells unless counterbalanced by cytokine survival signals.Immunity2013
  • 1 - 50 of 232

Recommended Authors

University of Alabama at Birmingham Birmingham
Career Start Year 2009
Number of shared co-authors 0
Peking University
Career Start Year 2009
Number of shared co-authors 0
University of Washington
Career Start Year 1998
Number of shared co-authors 1
Stanford University
Career Start Year 1997
Number of shared co-authors 0
Near-InfraRed Photo-Immunotherapy Research Institute, Kansai Medical University
Career Start Year 1996
Number of shared co-authors 1
Center for Spatial and Functional Genomics, Children's Hospital of Philadelphia
Career Start Year 1996
Number of shared co-authors 2
University of Texas MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 0
Cellular Dynamics International Inc.
Career Start Year 1995
Number of shared co-authors 1
University Health Network, Princess Margaret Cancer Centre
Career Start Year 1995
Number of shared co-authors 0
University of Alabama at Birmingham
Career Start Year 1995
Number of shared co-authors 0
The Rockefeller University
Career Start Year 1994
Number of shared co-authors 2
Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham
Career Start Year 1993
Number of shared co-authors 0
Baylor College of Medicine
Career Start Year 1992
Number of shared co-authors 0
Institute for Life and Medical Sciences, Kyoto University
Career Start Year 1991
Number of shared co-authors 2
St. Jude Children's Research Hospital
Career Start Year 1989
Number of shared co-authors 1
Princess Margaret Cancer Centre, Ontario Cancer Institute, University Health Network
Career Start Year 1989
Number of shared co-authors 2
Graduate School of Medicine, Osaka University
Career Start Year 1989
Number of shared co-authors 0
Helen Wills Neuroscience Institute, University of California berkeley
Career Start Year 1988
Number of shared co-authors 1
Merck & Co. Inc.
Career Start Year 1987
Number of shared co-authors 0
Princess Margaret Cancer Centre/University Health Network
Career Start Year 1986
Number of shared co-authors 0
Fox Chase Cancer Center
Career Start Year 1986
Number of shared co-authors 6
The University of Texas MD Anderson Cancer Center
Career Start Year 1984
Number of shared co-authors 0
La Jolla Institute for Immunology
Career Start Year 1983
Number of shared co-authors 4
University of Nebraska Medical Center
Career Start Year 1980
Number of shared co-authors 0
University of Alabama at Birmingham and Birmingham VA Medical Center.
Career Start Year 1978
Number of shared co-authors 1
RIKEN BioResource Research Center
Career Start Year 1975
Number of shared co-authors 0
The Jackson Laboratory Cancer Center
Career Start Year 1971
Number of shared co-authors 4
The University of Texas MD Anderson Cancer Center
Career Start Year 1970
Number of shared co-authors 3
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1970
Number of shared co-authors 4
RIKEN Center for Integrative Medical Sciences (IMS)
Career Start Year 1966
Number of shared co-authors 2

Collaborators

National Cancer Institute, National Institutes of Health
Co-authored papers 8
Co-authored papers 7
National Cancer Institute, National Institutes of Health (NIH)
Co-authored papers 5
Center for Cancer Research, National Cancer Institute
Co-authored papers 4
Center for Cancer Research, National Cancer Institute
Co-authored papers 4
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 4
Center for Cancer Research, National Cancer Institute
Co-authored papers 4
Brigham and Women's Hospital
Co-authored papers 3
Center for Cancer Research
Co-authored papers 3
Co-authored papers 3
Program Resources Inc. NCI-FCDRC
Co-authored papers 3
Center for Cancer Training, National Cancer Institute, National Institutes of Health
Co-authored papers 3
Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research
Co-authored papers 2
National Cancer Institute, National Institutes of Health
Co-authored papers 2
Co-authored papers 2
Center for Cancer Research, National Cancer Institute
Co-authored papers 2
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 2
Oncology R&D
Co-authored papers 2
Johns Hopkins School of Medicine, National Cancer Institute, Princeton University, University of Colorado Anschutz Medical Campus, University of Pittsburgh, University of Washington
Co-authored papers 2
National Eye Institute, National Institutes of Health
Co-authored papers 2
Co-authored papers 2
Center for Cancer Research
Co-authored papers 2
National Cancer Institute, National Institutes of Health
Co-authored papers 2
Co-authored papers 2
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 2
National Cancer Institute
Co-authored papers 2
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 2
University of Texas at Austin
Co-authored papers 2
Co-authored papers 2
Mission Therapeutics Ltd. Glenn Berge Building
Co-authored papers 2